Brigham Hyde

Brigham Hyde has a diverse and extensive work experience. In 2014, they served as the Chief Data Officer and Senior Vice President of Analytics at Decision Resources. In 2017, they co-founded and served as the CEO of Precision Health AI, which later became Concerto Health AI. Brigham also worked as a Partner at SymphonyAI and as the Co-Founder and President of Concerto HealthAI. In 2016, they were a Research Affiliate at Massachusetts Institute of Technology (MIT) and an Adjunct Professor of Pharmacology and Experimental Therapeutics at Tufts University since 2012. Brigham was also an Official Member of Forbes Technology Council from 2018 to 2022. Recently, they joined EVERSANA as the President and Atropos Health as the Chief Executive Officer. In 2023, they became a Venture Partner at Audere Capital LLC.

Brigham Hyde's education history includes a Ph.D. in Pharmacology and Experimental Therapeutics, which was obtained from Tufts University School of Medicine between 2004 and 2009. Prior to that, between 1999 and 2004, they earned a Bachelor of Science (BS) degree in Chemistry from Northeastern University. Before their college education, from 1996 to 1999, they attended Stowe High School, but no degree or field of study information is available for this period. Additionally, there is no specific information provided about any obtained certifications.